Home infusion program with enzyme replacement therapy for Fabry disease: The experience of a large Italian collaborative group

Fabry disease (FD) [OMIM 301500] is an X-linked lysosomal storage disorder caused by a deficiency of the lysosomal enzyme alpha-galactosidase A, resulting in progressive multisystem accumulation of globotriaosylceramide (Gb3). Although the introduction of Enzyme Replacement Therapy (ERT) resulted in...

Descripción completa

Detalles Bibliográficos
Autores principales: Concolino, D., Amico, L., Cappellini, M.D., Cassinerio, E., Conti, M., Donati, M.A., Falvo, F., Fiumara, A., Maccarone, M., Manna, R., Matucci, A., Musumeci, M.B., Nicoletti, A., Nisticò, R., Papadia, F., Parini, R., Peluso, D., Pensabene, L., Pisani, A., Pistone, G., Rigoldi, M., Romani, I., Tenuta, M., Torti, G., Veroux, M., Zachara, E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5484973/
https://www.ncbi.nlm.nih.gov/pubmed/28702361
http://dx.doi.org/10.1016/j.ymgmr.2017.06.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5484973/
https://www.ncbi.nlm.nih.gov/pubmed/28702361
http://dx.doi.org/10.1016/j.ymgmr.2017.06.005

Ejemplares similares